Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex
- PMID: 11804619
- DOI: 10.1016/s0028-3908(01)00172-1
Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex
Abstract
Gabapentin and pregabalin (S-(+)-3-isobutylgaba) produced concentration-dependent inhibitions of the K(+)-induced [Ca(2+)](i) increase in fura-2-loaded human neocortical synaptosomes (IC(50)=17 microM for both compounds; respective maximal inhibitions of 37 and 35%). The weaker enantiomer of pregabalin, R-(-)-3-isobutylgaba, was inactive. These findings were consistent with the potency of these drugs to inhibit [(3)H]-gabapentin binding to human neocortical membranes. The inhibitory effect of gabapentin on the K(+)-induced [Ca(2+)](i) increase was prevented by the P/Q-type voltage-gated Ca(2+) channel blocker omega-agatoxin IVA. The alpha 2 delta-1, alpha 2 delta-2, and alpha 2 delta-3 subunits of voltage-gated Ca(2+) channels, presumed sites of gabapentin and pregabalin action, were detected with immunoblots of human neocortical synaptosomes. The K(+)-evoked release of [(3)H]-noradrenaline from human neocortical slices was inhibited by gabapentin (maximal inhibition of 31%); this effect was prevented by the AMPA receptor antagonist NBQX (2,3-dioxo-6-nitro-1,2,3,4-tetrahydro[f]quinoxaline-7-sulphonamide). Gabapentin and pregabalin may bind to the Ca(2+) channel alpha 2 delta subunit to selectively attenuate depolarization-induced Ca(2+) influx of presynaptic P/Q-type Ca(2+) channels; this results in decreased glutamate/aspartate release from excitatory amino acid nerve terminals leading to a reduced activation of AMPA heteroreceptors on noradrenergic nerve terminals.
Similar articles
-
Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices.Br J Pharmacol. 2000 Jun;130(4):900-6. doi: 10.1038/sj.bjp.0703380. Br J Pharmacol. 2000. PMID: 10864898 Free PMC article.
-
Effects of gabapentin and pregabalin on K+-evoked 3H-GABA and 3H-glutamate release from human neocortical synaptosomes.Naunyn Schmiedebergs Arch Pharmacol. 2009 Apr;379(4):361-9. doi: 10.1007/s00210-008-0370-z. Epub 2008 Nov 11. Naunyn Schmiedebergs Arch Pharmacol. 2009. PMID: 19002437
-
Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin.Neurosci Lett. 2000 Feb 18;280(2):107-10. doi: 10.1016/s0304-3940(00)00769-2. Neurosci Lett. 2000. PMID: 10686389
-
Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.Epilepsy Res. 2007 Feb;73(2):137-50. doi: 10.1016/j.eplepsyres.2006.09.008. Epub 2006 Nov 28. Epilepsy Res. 2007. PMID: 17126531 Review.
-
Acute modulation of calcium currents and synaptic transmission by gabapentinoids.Channels (Austin). 2010 Nov-Dec;4(6):490-6. doi: 10.4161/chan.4.6.12864. Epub 2010 Nov 1. Channels (Austin). 2010. PMID: 21150315 Review.
Cited by
-
Influence of aminophylline on the anticonvulsive action of gabapentin in the mouse maximal electroshock seizure threshold model.J Neural Transm (Vienna). 2007;114(12):1539-45. doi: 10.1007/s00702-007-0795-4. Epub 2007 Aug 24. J Neural Transm (Vienna). 2007. PMID: 17713718
-
The analgesic effect of pregabalin in patients with chronic pain is reflected by changes in pharmaco-EEG spectral indices.Br J Clin Pharmacol. 2012 Mar;73(3):363-72. doi: 10.1111/j.1365-2125.2011.04104.x. Br J Clin Pharmacol. 2012. PMID: 21950372 Free PMC article. Clinical Trial.
-
Neuroprotective Properties of Antiepileptics: What are the Implications for Psychiatric Disorders?Curr Med Chem. 2024;31(23):3447-3472. doi: 10.2174/0929867330666230523155728. Curr Med Chem. 2024. PMID: 37226791 Review.
-
A group sequential response-adaptive randomized double-blinded clinical trial to evaluate the safety and efficacy of add-on olanzapine plus pregabalin for the prevention of chemotherapy-induced nausea and vomiting.Support Care Cancer. 2025 Feb 19;33(3):203. doi: 10.1007/s00520-025-09275-2. Support Care Cancer. 2025. PMID: 39969577 Clinical Trial.
-
(-)-Trans-Δ9-Tetrahydrocannabinol-Like Discriminative-Stimulus Effects of Gabapentin in Cannabis Users.J Alcohol Drug Depend. 2016 Feb;4(1):e129. doi: 10.4172/2329-6488.1000e129. Epub 2016 Feb 10. J Alcohol Drug Depend. 2016. PMID: 27376100 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous